Gebyar Ayu Ratih Kartika*, Cicilia Windiyaningsih and Samingan

Universitas Respati Indonesia, Indonesia

*Corresponding Author: Gebyar Ayu Ratih Kartika, Universitas Respati Indonesia, Indonesia.

Received: December 02, 2024; Published: February 10, 2025

Abstract

Tuberculosis (TB) is an infectious disease that is the leading cause of death worldwide, with major challenges in its control in Indonesia. Presidential Regulation Number 67 of 2021 and Decree of the Minister of Health Number HK.01.07/MENKES/2070/2023 regulate the financing mechanism and governance of TB in Indonesia. This study aims to evaluate the implementation of the Decree of the Minister of Health regarding innovation in financing of TB programs in primary health care facilities (FKTP) in North Jakarta. This study uses a mixed method with an embedded approach. Qualitative participants included the Head of the North Jakarta Health Office, TB Program Manager, and Head of Health Centre’s. Quantitative samples involved 6 health centres’ that implemented the new payment mechanism. The results of the qualitative study showed that the implementation of the TB financing program was running quite well, supported by adequate human resources and facilities, although ongoing training and improved data access were needed. Effective policies accelerated TB management, especially in patient referrals, although management of drugs approaching their expiration date still needed to be improved. Quantitative results showed some concerns regarding limited human resources and drug availability, although existing facilities and policies were considered adequate. Output indicators showed fairly good case finding, enrolment rate, and treatment success rate, with a loss to follow up rate of 10%. In conclusion, the program was running well but needed to improve human resource training and drug management. The researchers recommend ongoing training for health workers in FKTP and periodic evaluation of the implementation of the TB financing policy

 Keywords: Financing; Control; TB

References

1. “Global Tuberculosis Report”. (2018).
2. Indonesian Ministry of Health. “Tuberculosis Control Program”. Tuberculosis Control Program Report; (2022).
3. World Health Organization. “Global Tuberculosis Report 2020”. (2020).
4. Dewi Harimurti. “Tuberculosis elimination in Indonesia: Progress and challenges”. Lancet Infectious Disease9 (2021).
5. Fitriani Widjaja Koesoemadinata. “The role of community health workers in tuberculosis control in Indonesia”. BMC Public Health1 (2022): 1-10.
6. Uplekar M. “WHO's new End TB Strategy”. The Lancet (2016).
7. Floyd K., et al. “The global tuberculosis epidemic and progress in care, prevention, and research: an overview in year 3 of the End TB era”. Lancet Respiratory Medicine4 (2017): 299-314.
8. Lönnroth K., et al. “Public-private mix for TB care and control: A systematic review”. International Journal of Tuberculosis and Lung Disease1 (2015): 35-45.
9. Yadav K and Chadha S. “Barriers and enablers for implementing TB control strategies in India”. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases (2020).
10. Sreeramareddy CT. “Time delays in diagnosis of pulmonary tuberculosis: a systematic review of the literature”. BMC Infectious Disease1 (2014): 1-10.
11. “Strengthening Health Systems to Improve Health Outcomes: WHO's Framework for Action”. (2019).
12. Li Y. “The Impact of Health Workforce Strengthening on Improved Health Services in Low and Middle-Income Countries Diagnostic Challenges in Tuberculosis Control in Low-Resource Settings”. Global Health Action (2022).
13. Diti NH. “Challenges and Strategies in Rotational Deployment of Health Workers”. Journal of Public Health Management (2020).
14. Muleme J. “Diagnostic Challenges in Tuberculosis Control in Low-Resource Settings”. Global Health Action (2022).
15. Rukmini E. “Barriers to Early Diagnosis of Tuberculosis in Indonesia: A Qualitative Study”. BMC Public Health (2018).
16. Tuberculosis Working Team, Directorate of Prevention and Control of Communicable Diseases, Directorate General of Disease Prevention and Control. Update on Tuberculosis Diagnosis Flow and Treatment Follow-up Policy, Ministry of Health (2020).
17. Martin G. “The Role of Stakeholder Engagement in Program Implementation: A Case Study of Health Programs in Low-Income Settings”. (2019).
18. , et al. “Implementation of Government Policy: Minister of Health Regulation no. 67 of 2016 For Tuberculosis Prevention In Tuberculosis Prevention In Yogyakarta City, Indonesia”. JKKI 9 (2020).
19. Choameroh S. “Evaluation of Tuberculosis Prevention and Control Programs at Purwoyoso Health Center and Karangmalang Health Center, Semarang City”. In Semarang: Semarang State University (2020).
20. Sitorus S., et al. “Case Study of Financing for the Implementation of Tuberculosis Programs During the Covid-19 Pandemic in Medan City”. Indonesian Health Policy Journal: JKKI 11 (2020).
21. Arora P. “Impact of Training Programs and Technology on Tuberculosis Case Detection in Urban Health Centers”. Journal of Tuberculosis Research (2022).
22. Bukhari A. ‘Challenges in Tuberculosis Detection in Low-Resource Settings: Lessons Learned”. International Journal of Tuberculosis and Lung Disease (2021).
23. Hussain R. “Data-Driven Approaches to Improving Tuberculosis Detection and Treatment”. Global Health Action (2023).
24. Al-Moamary M., et al. “The Saudi Initiative for Asthma-2021 Update: Guidelines for the diagnosis and management of asthma in adults and children”. Annals of Thoracic Medicine. Wolters Kluwer Medknow Publications 16 (2021): 4-56.
25. Nguyen TH. “Challenges in Tuberculosis Patient Enrollment and Registration in Urban Health Centers”. International Journal of Tuberculosis and Lung Disease (2022).
26. Kumar A. “Analyzing Best Practices and Overcoming Barriers in Tuberculosis Patient Enrollment”. Global Health Action (2023).
27. Mitnick CD. “Challenges in Patient Retention and Follow-Up in Tuberculosis Programs”. American Journal of Respiratory and Critical Care Medicine (2021).
28. Munyakazi J. “Effective Strategies for Reducing Loss to Follow-Up in Tuberculosis Programs”. International Journal of Tuberculosis and Lung Disease (2022).
29. Baker MA. “Improving Tuberculosis Patient Retention through Enhanced Monitoring and Support Systems”. (2023).
30. Ayu M. “Strategies and Practices Leading to High Treatment Success Rates in Tuberculosis Programs”. Journal of Tuberculosis Research (2022).
31. Bertolani A. “Barriers to High Treatment Success Rates in Tuberculosis Programs: A Review”. International Journal of Tuberculosis and Lung Disease (2021).
32. Gibson H. “Improving Tuberculosis Treatment Success Rates: Lessons Learned from Successful Programs”. Global Health Action (2023).
33. Smith R. “Efficiency in Claims Processing and Management in Health Programs”. Journal of Health Economics (2021).
34. Johnston A and Holt DW. “Substandard drugs: A potential crisis for public health”. British Journal of Clinical Pharmacology 2 (2014): 218-243.
35. Lee K. “Financial Support and Claims Management in Health Programs”. Global Health Action (2023).
36. Wang H. “Health Service Utilization and Claims Patterns in Urban Areas”. Journal of Urban Health (2021).
37. Brown A. “Barriers to Health Service Utilization and Their Impact on Claims”. Health Service Research (2022).
38. Smith R. “Patterns in Health Claims and Service Utilization: A Comparative Study”. Journal of Health Economy (2022).

Citation

Citation: Gebyar Ayu Ratih Kartika., et al. “Evaluation of the Implementation of the Decree of the Minister of Health of the Republic of Indonesia Concerning Innovation in Financing of TB Control Programs in Primary Health Care Facilities (FKTP) in North Jakarta 2024”.Acta Scientific Medical Sciences 9.3 (2025): 33-42.

Copyright

Copyright: © 2025 Gebyar Ayu Ratih Kartika., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.